טוען...
Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group
Background: There is ample evidence of important symptomatic efficacy of tumour necrosis factor α (TNFα) inhibition in ankylosing spondylitis (AS). Moreover, studies suggest that anti-TNF could be considered as the first disease controlling antirheumatic treatment (DC-ART) for AS. Objective: To dete...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2003
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1754653/ https://ncbi.nlm.nih.gov/pubmed/12922951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.9.812 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|